Market Research Logo

Global mRNA Vaccines & Therapeutics Market Growth 2019-2024

Global mRNA Vaccines & Therapeutics Market Growth 2019-2024

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.
The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.

According to this study, over the next five years the mRNA Vaccines & Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in mRNA Vaccines & Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study considers the mRNA Vaccines & Therapeutics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Infectious Disease
Cancer
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global mRNA Vaccines & Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of mRNA Vaccines & Therapeutics market by identifying its various subsegments.
Focuses on the key global mRNA Vaccines & Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the mRNA Vaccines & Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of mRNA Vaccines & Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please note: The report will take approximately 2 business days to prepare and deliver.


1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Vaccines & Therapeutics Consumption 2014-2024
2.1.2 mRNA Vaccines & Therapeutics Consumption CAGR by Region
2.2 mRNA Vaccines & Therapeutics Segment by Type
2.2.1 Standardization Of Cancer Treatment MRNA Vaccine
2.2.2 Individualized Cancer Treatment MRNA Vaccine
2.2.3 Infectious Disease Treatment MRNA Vaccine
2.2.4 Infection Prevention MRNA Vaccine
2.3 mRNA Vaccines & Therapeutics Consumption by Type
2.3.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2014-2019)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2014-2019)
2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2014-2019)
2.4 mRNA Vaccines & Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Other
2.5 mRNA Vaccines & Therapeutics Consumption by Application
2.5.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Application (2014-2019)
2.5.2 Global mRNA Vaccines & Therapeutics Value and Market Share by Application (2014-2019)
2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2014-2019)
3 Global mRNA Vaccines & Therapeutics by Players
3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Players
3.1.1 Global mRNA Vaccines & Therapeutics Sales by Players (2017-2019)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Players (2017-2019)
3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Players
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Players (2017-2019)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Players (2017-2019)
3.3 Global mRNA Vaccines & Therapeutics Sale Price by Players
3.4 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 mRNA Vaccines & Therapeutics by Regions
4.1 mRNA Vaccines & Therapeutics by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Consumption by Regions
4.1.2 Global mRNA Vaccines & Therapeutics Value by Regions
4.2 Americas mRNA Vaccines & Therapeutics Consumption Growth
4.3 APAC mRNA Vaccines & Therapeutics Consumption Growth
4.4 Europe mRNA Vaccines & Therapeutics Consumption Growth
4.5 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Growth
5 Americas
5.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries
5.1.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
5.1.2 Americas mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
5.2 Americas mRNA Vaccines & Therapeutics Consumption by Type
5.3 Americas mRNA Vaccines & Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC mRNA Vaccines & Therapeutics Consumption by Countries
6.1.1 APAC mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
6.1.2 APAC mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
6.2 APAC mRNA Vaccines & Therapeutics Consumption by Type
6.3 APAC mRNA Vaccines & Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe mRNA Vaccines & Therapeutics by Countries
7.1.1 Europe mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
7.1.2 Europe mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
7.2 Europe mRNA Vaccines & Therapeutics Consumption by Type
7.3 Europe mRNA Vaccines & Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Countries
8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Type
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 mRNA Vaccines & Therapeutics Distributors
10.3 mRNA Vaccines & Therapeutics Customer
11 Global mRNA Vaccines & Therapeutics Market Forecast
11.1 Global mRNA Vaccines & Therapeutics Consumption Forecast (2019-2024)
11.2 Global mRNA Vaccines & Therapeutics Forecast by Regions
11.2.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2019-2024)
11.2.2 Global mRNA Vaccines & Therapeutics Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global mRNA Vaccines & Therapeutics Forecast by Type
11.8 Global mRNA Vaccines & Therapeutics Forecast by Application
12 Key Players Analysis
12.1 Moderna Therapeutics
12.1.1 Company Details
12.1.2 mRNA Vaccines & Therapeutics Product Offered
12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Moderna Therapeutics News
12.2 CureVac
12.2.1 Company Details
12.2.2 mRNA Vaccines & Therapeutics Product Offered
12.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 CureVac News
12.3 Translate Bio
12.3.1 Company Details
12.3.2 mRNA Vaccines & Therapeutics Product Offered
12.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Translate Bio News
12.4 BioNTech
12.4.1 Company Details
12.4.2 mRNA Vaccines & Therapeutics Product Offered
12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 BioNTech News
12.5 Sangamo Therapeutics
12.5.1 Company Details
12.5.2 mRNA Vaccines & Therapeutics Product Offered
12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Sangamo Therapeutics News
12.6 Argos Therapeutics
12.6.1 Company Details
12.6.2 mRNA Vaccines & Therapeutics Product Offered
12.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Argos Therapeutics News
12.7 In-Cell-Art
12.7.1 Company Details
12.7.2 mRNA Vaccines & Therapeutics Product Offered
12.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 In-Cell-Art News
12.8 eTheRNA
12.8.1 Company Details
12.8.2 mRNA Vaccines & Therapeutics Product Offered
12.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 eTheRNA News
12.9 Ethris
12.9.1 Company Details
12.9.2 mRNA Vaccines & Therapeutics Product Offered
12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Ethris News
12.10 Tiba Biotechnology
12.10.1 Company Details
12.10.2 mRNA Vaccines & Therapeutics Product Offered
12.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Tiba Biotechnology News
13 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report